Reports of Radiotherapy and Oncology

Published by: Kowsar

Toxicity, Efficacy, and Quality of Life of Addition of IMRT Boost to Whole Brain Radiation Therapy and Concurrent Temozolomide in Patients with Newly Diagnosed Brain Metastases

Naveen Thimmaiah 1 , * , Ajay G V 1 , Rahul Loni 1 , Tanvir Pasha 1 , Poojar Sridhar 1 and Lokesh V 1
Authors Information
1 Department of Radiation Oncology, Kidwai Cancer Institute, Bangalore, India
Article information
  • Reports of Radiotherapy and Oncology: December 2015, 2 (4); e10987
  • Published Online: December 31, 2015
  • Article Type: Research Article
  • Received: October 11, 2015
  • Revised: November 11, 2015
  • Accepted: December 15, 2015
  • DOI: 10.5812/rro.10987

To Cite: Thimmaiah N, V A G, Loni R, Pasha T, Sridhar P, et al. Toxicity, Efficacy, and Quality of Life of Addition of IMRT Boost to Whole Brain Radiation Therapy and Concurrent Temozolomide in Patients with Newly Diagnosed Brain Metastases, Rep Radiother Oncol. 2015 ;2(4):e10987. doi: 10.5812/rro.10987.

Abstract
Copyright © 2015, Reports of Radiotherapy and Oncology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Footnote
References
  • 1. Posner JB. Neurologic Complications of Cancer. 1995;
  • 2. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst. 2003; 95(17): 1276-99[DOI][PubMed]
  • 3. Cloughesy T, Selch MT, Liau L. Haskell CM: Cancer Treatment. 2001; : 1106-42
  • 4. Tsukada Y, Fouad A, Pickren JW, Lane WW. Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer. 1983; 52(12): 2349-54[DOI][PubMed]
  • 5. Murray KJ, Scott C, Greenberg HM, Emami B, Seider M, Vora NL, et al. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. Int J Radiat Oncol Biol Phys. 1997; 39(3): 571-4[DOI][PubMed]
  • 6. Antonadou D, Paraskevaidis M, Sarris G, Coliarakis N, Economou I, Karageorgis P, et al. Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol. 2002; 20(17): 3644-50[DOI][PubMed]
  • 7. Edwards AA, Keggin E, Plowman PN. The developing role for intensity-modulated radiation therapy (IMRT) in the non-surgical treatment of brain metastases. Br J Radiol. 2010; 83(986): 133-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments